research use only
Cat.No.S3802
| Related Targets | Integrase Antibiotics Anti-infection Fungal Antiviral COVID-19 Parasite Reverse Transcriptase HIV HCV Protease |
|---|---|
| Other Bacterial Inhibitors | Berberine BTZ043 Racemate Teicoplanin Ornidazole Skatole Berberine Sulfate Pipemidic acid Ceftiofur PBTZ169 Aminothiazole |
|
In vitro |
DMSO
: 18 mg/mL
(103.68 mM)
|
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 173.6 | Formula | C7H8NO2.Cl |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 6138-41-6 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | Nicotinic acid N-methylbetaine Hydrochloride, Coffearine Hydrochloride, Gynesine Hydrochloride | Smiles | C[N+]1=CC=CC(=C1)C(=O)O.[Cl-] | ||
| In vitro |
Trigonelline suppresses lipid droplet accumulation in a concentration (75 and 100 μM) dependent manner. Treatment of adipocyte with of Trigonelline down-regulates the peroxisome proliferator-activated receptor (PPAR) and CCAAT element binding protein (C/EBP- ) mRNA expression, which leads to further down regulation of other gene such as adiponectin, adipogenin, leptin, resistin andadipocyte fatty acid binding protein (aP2) as compared with respective control cells on 5th and 10thday of differentiation .
|
|---|---|
| In vivo |
Trigonelline has been shown to reduce diabetic auditory neuropathy and platelet aggregation. In rabbits, the main parameters for the fenugreek extract (i.g.) are as follows: T1/2(Ka)=0.9 h, T1/2(Ke)=2.2 h, V=0.64 L/kg, area under the curve=1.93 mg/min/L. The main parameters for trigonelline (i.v.) are as follows: T1/2α=10.8 min, T1/2β=44.0 min, K21=0.044/min, K10=0.026/min, K12=0.017/min, area under the concentration-time curve=931.0 mg/min/L. Trigonelline has a moderate rate of absorption and high rate of elimination in the rabbit. Trigonelline has beneficial effects in several human diseases, notably diabetes and central nervous system disease. Its properties include hypoglycemic, hypolipidemic, improving diabetic auditory neuropathy, neuroprotective, antimigraine, sedative, antibacterial, antiviral, and anti-tumor activities; it also improves memory retention and inhibits platelet aggregation.
|
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.